Tina Shih, PhD

Tina Shih, PhD

Professor, Department of Radiation Oncology

Languages

English

Education

Degrees

PhD, Stanford University, Stanford, CA, 1997
MA, National Tsing-Hua University, Hsinchu, Taiwan, 1990
BA, National Taiwan University, Taipei, Taiwan, 1988

Contact Information

Scientific Interests

Dr. Tina Shih's research focuses on cancer health economics research, which applies theories and methods of health economics to study economic aspects of cancer throughout the entire care continuum. Four main areas of her research within this emerging field are: (a) examining technology diffusion in cancer -- facilitators, barriers, health disparity implications and associated costs; (b) evaluating cost-effectiveness of cancer screening strategies or behavioral interventions and effectiveness of cancer policies; (c) applying econometric and statistical methods to analyze medical cost data and explore cost drivers; and (d) assessing and measuring cancer-related financial hardship longitudinally to inform the development of mitigation strategies through interventions or policy actions.       

Highlighted Publications

Shih YCT, Xu Y, Liu L, Smieliauskas F. Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries. Journal of Clinical Oncology. 2017; 35(22): 2484-2489.

Halpern MT, Shih YCT, Yabroff KR, Ekwueme DU, Bradley CJ, Davidoff AJ, Sabik JM, Lipscomb J. A Framework for Cancer Health Economics Research. Cancer. 2021; 127(7): 994- 996.

Shih YCT, Dong W, Xu Y, Etzioni R, Shen Y. Incorporating Breast Density in the Design of Optimal Screening Strategy for Breast Cancer: A Cost-Effectiveness Analysis. Annals of Internal Medicine. 2021; 174(4): 602-612.

Shih YCT, Owsley KM, Nicholas LH, Yabroff KR, Bradley C. Cancer’s Lasting Financial Burden: Evidence from a Longitudinal Assessment. JNCI. 2022 Jul 11;114(7):1020-1028.

Liu Y, Wang S, Li L, Xu Y, Shen Y, Tina Shih YC. Comparisons of Medical Cost Trajectories Between Non-Hispanic Black and Non-Hispanic White Patients With Newly Diagnosed Localized Prostate Cancer. Value Health. 2023 Jun 20:S1098-3015(23)03018-8. doi: 10.1016/j.jval.2023.06.003.